Viewing Study NCT03824704

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:50 PM
Ignite Modification Date: 2026-02-03 @ 3:55 AM
Study NCT ID: NCT03824704
Status: TERMINATED
Last Update Posted: 2023-06-12
First Post: 2019-01-21
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)
Sponsor: pharmaand GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epithelial Ovarian Cancer View
None Fallopian Tube Cancer View
None Primary Peritoneal Carcinoma View
None High Grade Serous Carcinoma View
None Endometrioid Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PARP View
None PARPi View
None PARP inhibitor View
None ARIES View
None Opdivo View
None Rucaparib View
None Nivolumab View
None PD-1 View
None BRCA View
None LOH View
None CO-338 View
None Immunotherapy View
None BMS-936558 View
None Clovis View
None Clovis Oncology View
None Rubraca View